Where does OCRA's clinical trial data come from?

OCRA indexes clinical trials from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Trials are matched to diseases, investigators, and funded research tracked across the platform.

How do I find clinical trials for ovarian cancer?

Search by condition, treatment type, trial phase, or NCT identifier. Each trial page shows current status, eligibility criteria, study locations, and a direct link to the ClinicalTrials.gov source record.

How often is clinical trial data updated?

Trial data is refreshed through periodic ingestion from the ClinicalTrials.gov v2 API. Status changes, new enrollments, and newly registered trials are captured during each update cycle.

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

NCT04763902CompletedNAINTERVENTIONAL

Summary

The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.

Key Facts

Lead Sponsor

University of Utah

Enrollment

Start Date

2021-02-18

Completion Date

2022-06-10

Study Type

INTERVENTIONAL

Official Title

Feasibility and Acceptability of Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

Interventions

Time Restricted Eating (TRE) Schedule

Conditions

Endometrial Neoplasms

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

All Aims:

* Native Hawaiian/Pacific Islander females aged 18 years or older
* Overweight or obese (BMI\>25kg/m2) OR have a history of non-insulin dependent diabetes OR have a history of complex atypical endometrial hyperplasia
* Have a working cell phone that can download an App
* Able to use cell phone during day (e.g. at work)
* Not a night shift worker

Applicable Only to Aims 2 \& 3:

* Able to attend study visits at the Huntsman Cancer Institute Center for HOPE

Exclusion Criteria:

All Aims:

* Unable to provide informed consent

Applicable Only to Aims 2 \& 3:

* Necessity of a special diet that precludes adjustment of meal timing and/or macronutrient content
* Have a history of insulin dependent diabetes
* Have a history of hysterectomy

Outcome Measures

Primary Outcomes

Proportion of Women Referred that are Consented

Feasibility of the TRE intervention will be measured by calculating a proportion (%) of women who were referred that were consented into the study. The study will be considered feasible if \> 70% of participants are consented and retained.